Abdurasman, Arasani -.

HRN: 23-11-17  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/24/2023
CIPROFLOXACIN 500MG (TAB)
05/24/2023
05/31/2023
ORAL
500mg/tab
BID
Uncomplicated UTI
Waiting Final Action 
05/24/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/24/2023
05/30/2023
IV
500 Mg
Q 8 Hours
Amebiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: